CNN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.310610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.256160E-01
Normal-vs-Stage2
1.463820E-01
Normal-vs-Stage3
4.417600E-01
Normal-vs-Stage4
5.547200E-01
Stage1-vs-Stage2
3.119600E-01
Stage1-vs-Stage3
4.018000E-01
Stage1-vs-Stage4
3.175600E-01
Stage2-vs-Stage3
9.146600E-01
Stage2-vs-Stage4
6.839800E-01
Stage3-vs-Stage4
8.482200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.339010E-01
Normal-vs-AfricanAmerican
5.999600E-01
Normal-vs-Asian
6.483900E-02
Caucasian-vs-AfricanAmerican
3.267800E-01
Caucasian-vs-Asian
1.336970E-01
AfricanAmerican-vs-Asian
8.329700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.386590E-01
Normal-vs-Female
1.451570E-01
Male-vs-Female
4.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.055200E-01
Normal-vs-Age(41-60Yrs)
3.598600E-01
Normal-vs-Age(61-80Yrs)
9.114200E-02
Normal-vs-Age(81-100Yrs)
3.126600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.283800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.438200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.880000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.744300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.638300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.315800E-02
Normal-vs-Daily Drinker
2.698400E-01
Normal-vs-Weekly Drinker
5.368000E-01
Normal-vs-Occasional Drinker
9.496300E-02
Normal-vs-Social Drinker
4.554200E-01
Non Drinker-vs-Daily Drinker
1.815960E-01
Non Drinker-vs-Weekly Drinker
2.899200E-01
Non Drinker-vs-Occasional Drinker
7.933600E-01
Non Drinker-vs-Social Drinker
2.180400E-01
Daily Drinker-vs-Weekly Drinker
8.742400E-02
Daily Drinker-vs-Occasional Drinker
1.089000E-01
Daily Drinker-vs-Social Drinker
6.255800E-02
Weekly Drinker-vs-Occasional Drinker
3.733600E-01
Weekly Drinker-vs-Social Drinker
9.298800E-01
Occasional Drinker-vs-Social Drinker
3.449000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.595200E-01
Normal-vs-Grade 2
7.118400E-01
Normal-vs-Grade 3
6.943200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.038960E-01
Grade 1-vs-Grade 3
3.276200E-01
Grade 1-vs-Grade 4
6.595200E-01
Grade 2-vs-Grade 3
5.233000E-01
Grade 2-vs-Grade 4
7.118400E-01
Grade 3-vs-Grade 4
6.943200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.836830E-01
Normal-vs-NonDiabetic
1.008390E-01
Diabetic-vs-NonDiabetic
8.329800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.343200E-01
Normal-vs-NoPancreatitis
1.491600E-01
Pancreatitis-vs-NoPancreatitis
3.658400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.316430E-01
Normal-vs-N1
1.546630E-01
N0-vs-N1
3.285600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.074500E-02
Normal-vs-TP53-NonMutant
1.037030E-01
TP53-Mutant-vs-TP53-NonMutant
6.840400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
